Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 6

Hypoxemia in patients with COPD: cause, effects, and disease progression

Authors Kent, Mitchell, McNicholas W

Published 14 March 2011 Volume 2011:6 Pages 199—208

DOI https://doi.org/10.2147/COPD.S10611

Review by Single-blind

Peer reviewer comments 3

Brian D Kent1,2, Patrick D Mitchell1, Walter T McNicholas1,2
1
Pulmonary and Sleep Disorders Unit, St. Vincent’s University Hospital, Dublin; 2Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland

Abstract: Chronic obstructive pulmonary disease (COPD) is a leading cause of death and disability internationally. Alveolar hypoxia and consequent hypoxemia increase in prevalence as disease severity increases. Ventilation/perfusion mismatch resulting from progressive airflow limitation and emphysema is the key driver of this hypoxia, which may be exacerbated by sleep and exercise. Uncorrected chronic hypoxemia is associated with the development of adverse sequelae of COPD, including pulmonary hypertension, secondary polycythemia, systemic inflammation, and skeletal muscle dysfunction. A combination of these factors leads to diminished quality of life, reduced exercise tolerance, increased risk of cardiovascular morbidity, and greater risk of death. Concomitant sleep-disordered breathing may place a small but significant subset of COPD patients at increased risk of these complications. Long-term oxygen therapy has been shown to improve pulmonary hemodynamics, reduce erythrocytosis, and improve survival in selected patients with severe hypoxemic respiratory failure. However, the optimal treatment for patients with exertional oxyhemoglobin desaturation, isolated nocturnal hypoxemia, or mild-to-moderate resting daytime hypoxemia remains uncertain.

Keywords: COPD, hypoxia, sleep, inflammation, pulmonary hypertension

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Silica nanoparticle-based dual imaging colloidal hybrids: cancer cell imaging and biodistribution

Lee H, Sung D, Kim J, Kim BT, Wang T, An SSA, Seo SW, Yi DK

International Journal of Nanomedicine 2015, 10:215-225

Published Date: 28 August 2015

Outcome of pulmonary rehabilitation in COPD patients with severely impaired health status

van Ranst D, Otten H, Meijer JW, van 't Hul AJ

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:647-657

Published Date: 1 December 2011

Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD

Rea H, Kenealy T, Adair J, Robinson E, Sheridan N

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:527-532

Published Date: 14 October 2011

Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease

Furutate R, Ishii T, Wakabayashi R, Motegi T, Yamada K, Gemma A, Kida K

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:423-430

Published Date: 8 August 2011

COPD and cognitive impairment: the role of hypoxemia and oxygen therapy

Neeta Thakur, Paul D Blanc, Laura J Julian, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:263-269

Published Date: 10 August 2010